Evidence map›Paper›PMID 23813825›Full record

ReviewJournal of feline medicine and surgery2013

Aspergillosis in cats: ABCD guidelines on prevention and management.

Katrin Hartmann, Albert Lloret, Maria Grazia Pennisi, Lluis Ferrer, Diane Addie, Sándor Belák, Corine Boucraut-Baralon, Herman Egberink, Tadeusz Frymus, Tim Gruffydd-Jones and 8 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of feline medicine and surgery, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 2 countries.

Katrin HartmannEuropean Advisory Board on Cat Diseases. Hartmann@medizinische-kleintierklinik.de
Albert Lloret
Maria Grazia Pennisi
Lluis Ferrer
Diane Addie
Sándor Belák
Corine Boucraut-Baralon
Herman Egberink
Tadeusz Frymus
Tim Gruffydd-Jones
Margaret J Hosie
Hans Lutz
Fulvio Marsilio
Karin Möstl
Alan D Radford
Etienne Thiry
Uwe Truyen
Marian C Horzinek
Advisory Board Company (United States) · USUniversity of Liège · BE

Funding

Biotechnology and Biological Sciences Research Council BB/D008425/1Medical Research Council G0300387
6 · The paper itself

Abstract

overviewAspergillosis is a sporadic mycosis that occurs worldwide in mammals and birds and leads to a usually chronic, and only rarely acute, disease that mainly affects the nasal cavity and sinuses. INFECTION: Aspergillus species infections are commonly associated with predisposing local or systemic factors. Local disease can spread and involve the central nervous system or the lungs. Some Aspergillus species can also disseminate, causing systemic infections. In contrast to dogs, in which (nasal) aspergillosis is relatively common, aspergillosis is rare in cats, but considered an emerging infection. CLINICAL SIGNS: There are two clinical forms of aspergillosis in cats, the sinonasal form (characterised by signs of chronic nasal infection) and the newly emerging, more invasive sino-orbital form (characterised by signs of orbital and surrounding tissue invasion). Sino-orbital involvement has been described now in approximately half of the reported cases. DISEASE MANAGEMENT: Treatment should consist of local and systemic antifungal therapy.

Indexed as

AnimalsAntifungal AgentsAspergillosisCat DiseasesCatsAntifungal Agents

Identifiers

PMID23813825
PMCPMC11148965
OpenAlexW1977709560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.